Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. It operates through the Biotechnology and Technology segments. The Biotechnology segment is involved in developing biotechnology product pipelines. The Technology segment relates to acquiring technology assets to support and enhance operational capabilities through advanced technologies. The company was founded in 2017 and is headquartered in Wexford, PA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
7
Frequently Asked Questions
What is Market Cap of Coeptis Therapeutics Holdings Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Coeptis Therapeutics Holdings Inc market cap is $59.92M.
What is the 52-week high for Coeptis Therapeutics Holdings Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Coeptis Therapeutics Holdings Inc 52 week high is $14.70 as of September 12, 2025.
What is the 52-week low for Coeptis Therapeutics Holdings Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Coeptis Therapeutics Holdings Inc 52 week low is $2.31 as of September 12, 2025.
What is Coeptis Therapeutics Holdings Inc stock price today?
Coeptis Therapeutics Holdings Inc stock price today is $12.89.
What was Coeptis Therapeutics Holdings Inc stock price yesterday?
Coeptis Therapeutics Holdings Inc stock price yesterday was $12.43.
What is the PE ratio of Coeptis Therapeutics Holdings Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Coeptis Therapeutics Holdings Inc’s P/E ratio is -2.90.
What is the Price-to-Book ratio of Coeptis Therapeutics Holdings Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Coeptis Therapeutics Holdings Inc P/B ratio is 8.3256.
What is the 50-day moving average of Coeptis Therapeutics Holdings Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Coeptis Therapeutics Holdings Inc 50-day moving average is $11.46.
How many employess does Coeptis Therapeutics Holdings Inc has?
Coeptis Therapeutics Holdings Inc has 7 employees.
